Showing 2021-2030 of 8825 results for "".
Fighting for Coverage: Combatting Private Insurance to Get Patients the Drugs They Need
https://practicaldermatology.com/issues/july-2025/fighting-for-coverage/36503/Aside from decreasing reimbursement rates, obtaining prior authorization from private insurance for medications that our patients desperately need to improve their lives, improve their skin conditions, and improve their wellbeing is probably the greatest challenge that dermatologists face today.Telephone Mystery Shopping and Converting New Patients
https://practicaldermatology.com/issues/april-2025/telephone-mystery-shopping-and-converting-new-patients/35621/Even with today’s market focused on online digital marketing, a practice’s biggest revenue source opportunity still seems to be the phones. The first interaction most new patients have with a practice is on the phone, which used to be about 99% of the time; now, we believe it is about 80%.Emrosi Launched in the US for Rosacea
https://practicaldermatology.com/series/dermwire-tv/emrosi-launched-in-the-us-for-rosacea/33943/In this week's DermwireTV, a new treatment for rosacea is launched in the US; long-term data is presented for tapinarof 1% cream for atopic dermatitis; and in our C-Suite Chats segment, we speak with the CEO and Co-Founder of Mama Sol.I Came In Like a Wrecking Ball
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/i-came-in-like-a-wrecking-ball/33162/I have to start by warning you, dear reader, that I am writing my first editorial for Practical Dermatology immediately after typing up four appeal letters to insurance companies.Updates in Vulvar Dermatology
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/updates-in-vulvar-dermatology/33012/Melissa Mauskar, MD, an associate professor and director of the vulvar heatlh program at UT Southwestern Medical Center, talks about the importance of having dermatologists promote vulvar health and regular examination, while also working to reduce patient anxiety.ISDPA: Dr. Lal on Therapeutic Updates
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-lal-therapeutic-updates/29149/Karan Lal, DO, discusses the latest therapeutic updates for atopic dermatitis and other conditions, including his strategies for utilizing dupilumab, at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.Bring Pediatric Pearls Into Practice
https://practicaldermatology.com/conferences/maui-derm-2024/bring-pediatric-pearls-into-practice/20265/Resident Of Distinction Award-winner Maria Buethe, MD, PhD, a pediatric dermatology fellow at Rady Children’s Hospital in San Diego, talks about her favorite session at Maui Derm 2024 sharing technical and practice pearls for the treatment of dermatological conditions in children, including an interWhat Could Go Wrong with Fillers?
https://practicaldermatology.com/conferences/maui-derm-2024/what-could-go-wrong-with-fillers/20253/Joel L. Cohen, MD, explains the importance of understanding “what lies beneath” in order to more accurately evaluate post-procedure reactions and know how and when to intervene.What’s New With Neuromodulators?
https://practicaldermatology.com/conferences/maui-derm-2024/whats-new-with-neuromodulators/20252/Joel L. Cohen, MD, discusses the currently available neuromodulators as well as what’s on the radar, including ready-to-use liquid toxins and more.Why It’s Critical to Distinguish Between Rosacea Subtypes for Best Results
https://practicaldermatology.com/conferences/maui-derm-2024/why-its-critical-to-distinguish-between-rosacea-subtypes-for-best-results/20245/In the Acne and Rosacea Updates symposium, Hilary Baldwin, MD, explained how she evaluates and treats rosacea with phenotypic therapies based on which aspects of the disease patients are most concerned about.